Scientific Advisory Committee
Andrew H. Kang, M.D.
| Center of Excellence for Diseases of Connective Tissue, University of Tennessee Health Science Center
University of Tennessee Health Science Center
|
University of Tennessee Health Science Center
- Professor of Biochemistry
Education/Training
- Harvard University Medical School, M.D.
- Internship and Residency, Peter Bent Brigham Hospital
- Fellowship, Massachusetts General Hospital
Research Interests
- Molecular mechanisms involved in the development of disorders of the connective tissues such as rheumatoid arthritis and systemic scleroderma
Representative Publications (out of 260)
- Sakurai Y, Tang B, Rosloniec EF, et al. Molecular characterization of an arthritogenic collagen peptide interacting with I-Ar. Immunology. 2006
Jan;117(1):136-42 - Carbone LD, Barrow KD, Bush AJ, et al. Effects of a low sodium diet on bone metabolism. J Bone Miner Metab. 2005;23(6):506-13.
- Kang AH. Traumatic spinal cord injury. Clin Obstet Gynecol. 2005 Mar;48(1):67-72.
- Tang B, Brand DD, Ma Z, et al. Pathogenesis of collagen-induced arthritis: modulation of disease by arthritogenic T-cell epitope location.
Immunology. 2004 Nov;113(3):384-91. - Myers LK, Tang B, Brand DD, et al. Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis. Arthritis Rheum. 2004
Sep;50(9):3004-11.
Patents
- 5,824,647—Chemotactic wound healing peptides
- 5,436,228—Chemotactic wound healing peptides